For Bayer, a Roundup Deal Would Be Billions Well Spent

Bookmark
(Bloomberg Opinion) -- Bayer AG shareholders are daring to imagine a future free of the litigation that has dogged the pharma group’s Roundup weedkiller. It’s an increasingly plausible scenario, an...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.